← Evidence map

ArticleGenes2019

Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients.

Yingqi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019
2020
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31466383